WALGREENS

NANTUCKET, Mass. — Walgreens CFO Wade Miquelon said that the chain's decision to break its ties with pharmacy benefit manager Express Scripts was the best decision, according to a Reuters report.

Caling it a "principled stand," Miquelon, who spoke at the Jefferies 2011 Global Consumer Conference in Nantucket, Mass., on Thursday, said that "under any scenario of what Express Scripts is proposing ... it's much better for us to go it alone," Reuters reported.

CAMP HILL, Pa. — Sales may have been flat overall, but a closer look revealed there was a lot to be positive about in Rite Aid’s fiscal first quarter 2012 earnings, as the company managed significant expense improvement and stronger same-store sales growth. Bottom line: Rite Aid narrowed its losses considerably, and that ain’t all expense control.

KINGSTON, Pa. — Rep. Tom Marino, R-Pa., on Monday propositioned a bill that would allow independent drug stores to band together in an effort to increase their collective pharmaceutical buying power.

ST. LOUIS — After Walgreens made its contract dispute with Express Scripts public on Tuesday morning, the pharmacy benefit manager stated it is open to continued negotiations with Walgreens.

DEERFIELD, Ill. — Walgreens has teamed with Greater Than AIDS, a national campaign in response to HIV/AIDS in the United States, to distribute informational resources and specialized HIV-related services at more than 300 Walgreens pharmacies in heavily affected communities, the Kaiser Family Foundation announced Tuesday. 

NEW YORK — Wine with an evening meal outdoors is one of the great pleasures of summer, and with summer officially beginning this week, this Walgreens store in Brooklyn is making sure customers have everything they need.

DEERFIELD, Ill. — Walgreens on Tuesday announced the company no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations.

DEERFIELD, Ill. — Soon after reporting double-digit earnings per share growth Tuesday morning, Walgreens announced it would forego as much as $5.3 billion in annual sales, representing some 7% of the company’s business and 90 million prescriptions, as it walks away from its relationship with pharmacy benefit manager Express Scripts.

Wall Street reacted badly to the news — sales of Walgreens’ stock were down more than 6% to $42 and change in mid-morning trading.